Table of Contents
Cough, Cold and Allergy (hay Fever) Remedies in Romania
Euromonitor
International
September 2009
List of Contents and Tables
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies
by Subsector: Value 2003-2008
Table 2 Sales of Cough, Cold and Allergy
(Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 3 Sales
of Decongestants by Type: Value 2003-2008
Table 4 Sales of Decongestants
by Type: % Value Growth 2003-2008
Table 5 Sales of Child-specific Cough,
Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 6
Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type:
% Value Growth 2003-2008
Table 7 Herbal vs Standard Cough, Cold and
Allergy (Hay Fever) Remedies 2003-2008
Table 8 Cough, Cold and Allergy
(Hay Fever) Remedies Company Shares by Value 2004-2008
Table 9 Cough, Cold
and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 10
Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector:
Value 2008-2013
Table 11 Forecast Sales of Cough, Cold and Allergy (Hay
Fever) Remedies by Subsector: % Value Growth 2008-2013
Antibiotice SA
Strategic Direction
Key Facts
Summary 1 Antibiotice SA: Key Facts
Summary 2 Antibiotice SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Antibiotice SA:
Competitive Position 2008
Biofarm SA
Strategic Direction
Key
Facts
Summary 4 Biofarm SA: Key Facts
Summary 5 Biofarm SA:
Operational Indicators
Company Background
Production
Competitive
Positioning
Summary 6 Biofarm SA: Competitive Position 2008
Ozone
Laboratories SRL
Strategic Direction
Key Facts
Summary 7 Ozone
Laboratories SRL: Key Facts
Summary 8 Ozone Laboratories SRL: Operational
Indicators
Company Background
Production
Competitive
Positioning
Summary 9 Ozone Laboratories SRL: Competitive Position
2008
Terapia Ranbaxy
Strategic Direction
Key Facts
Summary 10
Terapia Ranbaxy: Key Facts
Summary 11 Terapia Ranbaxy: Operational
Indicators
Company Background
Production
Competitive
Positioning
Summary 12 Terapia Ranbaxy: Competitive Position 2008
Zentiva SA
Strategic Direction
Key Facts
Summary 13 Zentiva SA:
Key Facts
Summary 14 Zentiva SA: Operational Indicators
Company
Background
Production
Competitive Positioning
Summary 15 Zentiva
SA: Competitive Position 2008
Executive Summary
Excellent Dynamics in
2008
Increased Purchasing Power Sustains Growth
Domestic Producers
Lead the Market
Chemists/pharmacies Maintains Its Dominance
Changing
Lifestyles Increase OTC Consumption
Key Trends and Developments
Ageing
Population Drives Market Performance
Growing Incomes Stimulate
Self-medication
OTC Healthcare Remains Highly Regulated
Modernisation
of Pharmacies Contributes To Sales Growth
Domestic Producers Lead the
Market
Rural Areas Represent Strong Growth Potential
Market
Indicators
Table 12 Consumer Expenditure on Health Goods and Medical
Services 2003-2008
Table 13 Life Expectancy at Birth 2003-2008
Market
Data
Table 14 Sales of OTC Healthcare by Sector: Value 2003-2008
Table
15 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 16
OTC Healthcare Company Shares by Value 2004-2008
Table 17 OTC Healthcare
Brand Shares by Value 2005-2008
Table 18 Sales of OTC Healthcare by
Distribution Format: % Analysis 2003-2008
Table 19 Sales of OTC Healthcare
by Sector and Distribution Format: % Analysis 2008
Table 20 Forecast Sales
of OTC Healthcare by Sector: Value 2008-2013
Table 21 Forecast Sales of
OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC
Registration and Classification
Vitamins & Dietary Supplements
Registration and Classification
Generics
Switches
Summary 16 OTC
Healthcare Switches 2005-2008
Definitions
Summary 17 Research
Sources
| 
View Cart
